Mounjaro reimbursement refusal risks creating 'two-tier healthcare'

The Belgian Association for the Study of Obesity regrets the refusal to reimburse Mounjaro for obese patients. It believes the decision could reserve this costly treatment for people with the highest incomes. The association warns that this could lead to a 'two-tier healthcare system' in obesity care.